CYTOSORBENTS CORPORATION (CTSO) Current Ratio
- Current ratio · latest quarter: Value 0.66×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 0.66× | Current assets / current liabilities. $15.74M ÷ $24.02M ≈ 0.66× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 15.74M USD | Assets, Current |
| Current obligations | 24.02M USD | Liabilities, Current |
| Cash and equivalents | 4.41M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 6.79M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 3.69M USD | Inventory, Net |
| Payables | 2.00M USD | Accounts Payable, Current |
| Borrowing debt due within one year | 14.15M USD | Long-term Debt, Current Maturities |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.74M | $24.02M | $4.41M | (m) | $6.79M | $3.69M | $2.00M | $14.15M | 0.66× |
| 2026-03-31 | $17.76M | $16.30M | $4.81M | (m) | $7.15M | $4.48M | $3.13M | $6.65M | 1.09× |
| 2025-12-31 | $20.63M | $9.71M | $6.25M | (m) | $7.55M | $5.28M | $2.87M | (m) | 2.13× |
| 2025-09-30 | $21.31M | $10.11M | $7.54M | (m) | $7.43M | $4.00M | $3.04M | (m) | 2.11× |
| 2025-06-30 | $22.99M | $9.84M | $10.20M | (m) | $7.74M | $3.71M | $3.39M | (m) | 2.34× |
| 2025-03-31 | $25.41M | $9.74M | $11.59M | (m) | $7.67M | $3.02M | $3.33M | (m) | 2.61× |
| 2024-12-31 | $21.60M | $9.82M | $3.28M | (m) | $7.32M | $2.73M | $3.34M | (m) | 2.20× |
| 2024-09-30 | $16.60M | $8.28M | (m) | (m) | (m) | $3.25M | (m) | (m) | 2.00× |
| 2024-06-30 | $21.96M | $9.64M | (m) | (m) | (m) | $4.32M | (m) | (m) | 2.28× |
| 2024-03-31 | $19.99M | $12.72M | (m) | (m) | (m) | $3.74M | (m) | (m) | 1.57× |
| 2023-12-31 | $25.40M | $14.04M | $14.13M | (m) | $6.06M | $3.38M | $3.80M | $2.50M | 1.81× |
| 2023-09-30 | $19.26M | $11.67M | (m) | (m) | (m) | $2.98M | (m) | (m) | 1.65× |
| 2023-06-30 | $23.64M | $9.99M | (m) | (m) | (m) | $2.05M | (m) | (m) | 2.37× |
| 2023-03-31 | $28.16M | $9.45M | (m) | (m) | (m) | $1.73M | (m) | (m) | 2.98× |
| 2022-12-31 | $33.76M | $9.71M | $22.14M | (m) | $5.66M | $3.46M | $1.66M | (m) | 3.48× |
| 2022-09-30 | $32.38M | $10.12M | $22.55M | (m) | $4.96M | $3.54M | $2.35M | (m) | 3.20× |
| 2022-06-30 | $41.65M | $10.55M | $30.16M | (m) | $5.17M | $4.98M | $2.13M | (m) | 3.95× |
| 2022-03-31 | $55.85M | $14.67M | $43.02M | (m) | $4.58M | $5.45M | $4.83M | (m) | 3.81× |
| 2021-12-31 | $64.30M | $13.69M | $52.14M | (m) | $4.52M | $4.77M | $2.81M | (m) | 4.70× |
| 2021-09-30 | $72.75M | $11.07M | $61.04M | (m) | $5.24M | $4.53M | $3.36M | (m) | 6.57× |
| 2021-06-30 | $77.08M | $10.80M | $65.61M | (m) | $5.75M | $3.69M | $2.17M | (m) | 7.14× |
| 2021-03-31 | $79.63M | $9.76M | $68.47M | (m) | $5.02M | $3.11M | $1.68M | (m) | 8.16× |
| 2020-12-31 | $82.45M | $10.15M | $71.42M | (m) | $5.16M | $2.67M | $1.84M | (m) | 8.12× |
| 2020-09-30 | $96.80M | $17.36M | $87.98M | (m) | $5.80M | $2.02M | $2.39M | $9.17M | 5.58× |
| 2020-06-30 | $41.95M | $15.66M | $35.11M | (m) | $3.89M | $1.99M | $2.73M | $6.67M | 2.68× |
| 2020-03-31 | $37.53M | $11.46M | $26.39M | (m) | $5.40M | $1.97M | $1.77M | $4.17M | 3.27× |
| 2019-12-31 | $20.90M | $9.94M | $12.23M | (m) | $4.47M | $2.11M | $2.04M | $1.67M | 2.10× |
| 2019-09-30 | $22.35M | $9.30M | $15.98M | (m) | $3.45M | $1.77M | $2.07M | $3.13M | 2.40× |
| 2019-06-30 | $22.21M | $6.92M | $16.34M | (m) | $3.45M | $1.46M | $2.15M | $833.33K | 3.21× |
| 2019-03-31 | $24.83M | $6.71M | $19.65M | (m) | $3.27M | $1.21M | $1.84M | $1.67M | 3.70× |
| 2018-12-31 | $28.26M | $6.92M | $22.37M | (m) | $3.94M | $833.13K | $1.49M | $666.67K | 4.09× |
| 2018-09-30 | $29.95M | $4.26M | $24.91M | (m) | $3.64M | $779.42K | $1.86M | $0.00 | 7.03× |
| 2018-06-30 | $30.78M | $3.49M | $25.28M | (m) | $2.90M | $769.25K | $1.25M | $0.00 | 8.82× |
| 2018-03-31 | $24.52M | $3.99M | $21.09M | (m) | $2.35M | $680.18K | $2.14M | $0.00 | 6.15× |
| 2017-12-31 | $20.74M | $7.85M | $17.32M | (m) | $2.21M | $795.66K | $1.24M | $4.00M | 2.64× |
| 2017-09-30 | $19.39M | $5.78M | $15.40M | (m) | $2.35M | $1.09M | $1.29M | $3.00M | 3.36× |
| 2017-06-30 | $19.74M | $6.23M | $16.40M | (m) | $2.06M | $889.74K | $1.58M | $2.00M | 3.17× |
| 2017-03-31 | $6.28M | $6.18M | $3.24M | (m) | $1.73M | $857.79K | $1.66M | $1.25M | 1.02× |
| 2016-12-31 | $7.83M | $4.28M | $5.25M | (m) | $1.43M | $833.98K | $1.33M | $833.33K | 1.83× |
| 2016-09-30 | $9.05M | $5.00M | $6.38M | (m) | $1.41M | $1.05M | $739.94K | $416.67K | 1.81× |
| 2016-06-30 | $11.07M | $3.93M | $8.67M | (m) | $944.78K | $1.05M | $1.02M | (m) | 2.82× |
| 2016-03-31 | $8.04M | $3.25M | $3.54M | (m) | $760.16K | $1.06M | $860.69K | (m) | 2.48× |
| 2015-12-31 | $9.86M | $3.04M | $5.32M | (m) | $648.87K | $1.19M | $684.63K | $0.00 | 3.24× |
| 2015-09-30 | $11.59M | $3.45M | $7.39M | (m) | $553.38K | $1.34M | $526.67K | (m) | 3.36× |
| 2015-06-30 | $13.04M | $2.53M | $8.02M | (m) | (m) | $1.06M | $417.72K | (m) | 5.16× |
| 2015-03-31 | $14.88M | $6.20M | $10.42M | (m) | (m) | $702.92K | $475.21K | (m) | 2.40× |
| 2014-12-31 | $7.61M | $4.51M | $3.61M | (m) | $819.15K | $537.57K | $698.31K | (m) | 1.69× |
| 2014-09-30 | $8.95M | $1.55M | $433.42K | (m) | (m) | $387.07K | $446.17K | (m) | 5.78× |
| 2014-06-30 | $10.62M | $2.77M | $4.88M | (m) | (m) | $303.69K | $525.96K | (m) | 3.84× |
| 2014-03-31 | $11.83M | $3.30M | $6.42M | (m) | (m) | $146.52K | $527.65K | (m) | 3.59× |
| 2013-12-31 | $3.49M | $3.06M | $2.18M | (m) | (m) | $245.61K | $786.52K | (m) | 1.14× |
| 2013-09-30 | $3.64M | $3.07M | $2.35M | (m) | (m) | $362.54K | $572.01K | (m) | 1.19× |
| 2013-06-30 | $2.59M | $2.10M | $1.87M | (m) | (m) | $476.55K | $720.56K | (m) | 1.23× |
| 2013-03-31 | $2.13M | $993.43K | $1.37M | (m) | (m) | $555.26K | $704.71K | (m) | 2.14× |
| 2012-12-31 | $2.94M | $2.08M | $1.73M | (m) | (m) | $682.37K | $800.67K | (m) | 1.42× |
| 2012-09-30 | $2.86M | $2.08M | $2.06M | (m) | (m) | $625.78K | $728.01K | (m) | 1.38× |
| 2012-06-30 | $2.47M | $2.30M | $1.74M | (m) | (m) | $535.26K | $620.85K | (m) | 1.07× |
| 2012-03-31 | $2.36M | $2.25M | $1.80M | (m) | $39.79K | $468.56K | $647.52K | (m) | 1.05× |
| 2011-12-31 | $1.70M | $1.53M | $1.19M | (m) | (m) | $431.02K | $675.16K | (m) | 1.11× |
| 2011-09-30 | $2.52M | $1.59M | $2.30M | (m) | (m) | $186.34K | $784.36K | (m) | 1.58× |
| 2011-06-30 | $3.45M | $1.42M | $3.42M | (m) | (m) | (m) | $832.62K | (m) | 2.43× |
| 2010-12-31 | $1.40M | $1.22M | $1.06M | (m) | (m) | (m) | $817.70K | (m) | 1.15× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |